Dispensing of Ivermectin From Veterans Administration Pharmacies During the COVID-19 Pandemic

Nora V Becker; Sarah Seelye; Kao-Ping Chua; Kelly Echevarria; Rena M Conti; Hallie C Prescott

doi:10.1001/jamanetworkopen.2022.54859

Dispensing of Ivermectin From Veterans Administration Pharmacies During the COVID-19 Pandemic

JAMA Netw Open. 2023 Feb 1;6(2):e2254859. doi: 10.1001/jamanetworkopen.2022.54859.

Authors

Nora V Becker¹, Sarah Seelye², Kao-Ping Chua³, Kelly Echevarria⁴, Rena M Conti⁵, Hallie C Prescott²

Affiliations

¹ Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor.
² VA Center for Clinical Management Research, Ann Arbor, Michigan.
³ Department of Pediatrics, University of Michigan, Ann Arbor.
⁴ Veterans Health Administration Pharmacy Benefits Management, San Antonio, Texas.
⁵ Questrom School of Business, Boston University, Boston, Massachusetts.

No abstract available

Plain language summary

This cohort study compares changes in ivermectin dispensing during the COVID-19 pandemic between the Veterans Administration (VA) and retail pharmacy settings and examines the association of the VA national formulary restriction with ivermectin dispensing.

Publication types

Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.

MeSH terms

COVID-19*
Humans
Ivermectin / therapeutic use
Pandemics
Pharmacies*
United States / epidemiology
United States Department of Veterans Affairs

Substances

Ivermectin

Plain language summary

Publication types

MeSH terms

Substances

Grants and funding